GL1X · GenesisL1 explorer

MolNFT v1 · #55582 · protein

Catalytic domain of mouse 2',3'-cyclic nucleotide 3'- phosphodiesterase, crystallized with 2'-amps

2YP0 · 2', 3'-cyclic nucleotide 3'-phosphodiesterase: “Catalytic domain of mouse 2',3'-cyclic nucleotide 3'- phosphodiesterase, crystallized with 2'-amps”. X-ray diffraction, 1 ligand (OVE), 2 pockets (best druggability 0.62). MolNFT v1…

PDB
2YP0
Type
protein
Length
210 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
2', 3'-cyclic nucleotide 3'-phosphodiesterase
EC
3.1.4.37
UniProt
P16330
Ligands
OVE
Pockets
2 · best druggability 0.62

Structure

x-ray diffraction · 1 distinct chain · 32% helix, 30% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A2', 3'-cyclic nucleotide 3'-phosphodiesterase (EC 3.1.4.37)protein21032% helix, 30% strandP16330

Ligands and binding sites

  • OVE · 2'-O-(sulfidophosphinato)adenosine · ligand · 2 copies · chains A
  • GOL · Glycerol · additive · chains A
  • 1PE · Pentaethylene glycol · additive · chains A
  • ACY · Acetic acid · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13350.620.7842OVE, ACY
2720.290.7320empty

Compared structures

  • 2YP0 · Catalytic domain of mouse 2',3'-cyclic nucleotide 3'- phosphodiesterase, crystallized… · the same entry in another collection · chain A against A, TM-score 1.00
  • P16330 · AlphaFold monomer V2.0 prediction for 2',3'-cyclic-nucleotide 3'-phosphodiesterase… · a predicted model of the same protein · chain A against A, TM-score 0.96

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.